Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Identification of Barbiturates

Abstract

IN Great Britain the most common poisons at the present time are the 5 : 5′ disubstituted barbiturates. The longer-acting barbiturates, barbitone and phenobarbitone, can accumulate in the body when administered in relatively low therapeutic dosage, and concentrations of these drugs in the blood of about 5 mgm./100 ml. do not necessarily imply poisoning. The shorter-acting barbiturates, when taken in therapeutic quantities, however, do not accumulate, and in such cases this concentration would imply that an excessive quantity had been taken.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Maher and Puckett, J. Lab. Clin. Med., 45, 806 (1955).

    CAS  PubMed  Google Scholar 

  2. Maynert and Washburn, J. Amer. Chem. Soc., 75, 700 (1953).

    Article  CAS  Google Scholar 

  3. Brooker, Analyst, 82, 448 (1957).

    Article  ADS  CAS  Google Scholar 

  4. Curry, Acta Pharmacol. and Toxicol., 13, 357 (1957).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

CURRY, A. Identification of Barbiturates. Nature 183, 1052 (1959). https://doi.org/10.1038/1831052a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/1831052a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing